Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emily F Goode"'
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
The need for predictive biomarkers that can accurately predict patients who will respond to immune checkpoint inhibitor (ICI) immunotherapies remains a clinically unmet need. The majority of research efforts have focused on expression of immune-relat
Externí odkaz:
https://doaj.org/article/f7a4ccdbc3fa444e9ff615ce7141361e
Publikováno v:
Molecular Cell. 76:232-242
Why do cells have so many ways to die? Why does "cellular suicide" exist at all? In the war against pathogens and rogue cells, organisms developed cellular suicide as a last resort. Fighting an evolutionary arms race, cell death pathways have adapted
Autor:
Nicolò Matteo Luca Battisti, Maria Sol Andres, Karla A Lee, Tharshini Ramalingam, Tamsin Nash, Stephanie Mappouridou, Nishanthi Senthivel, Kalaprapa Asavisanu, Mariam Obeid, Elli-Sophia Tripodaki, Vasileios Angelis, Emily Fleming, Emily F Goode, Susan John, Stuart D Rosen, Mark Allen, Susannah Stanway, Alexander R Lyon, Alistair Ring
PurposeTrastuzumab improves survival in patients with HER2+ early breast cancer. However, cardiotoxicity remains a concern, particularly in the curative setting, and there are limited data on its incidence outside of clinical trials. We retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc979bf5e03cc7af13cb3853bbee0744
https://doi.org/10.21203/rs.3.rs-251663/v1
https://doi.org/10.21203/rs.3.rs-251663/v1
Publikováno v:
Case Reports. 2013:bcr2012008405-bcr2012008405
Atrial myxomas are the most common primary cardiac tumours encountered. Their detection may be incidental, owing to embolic events, intracardiac obstructive features or in some cases, non-specific constitutional symptoms. We describe a middle-aged wo